ZnO2-SnO2: A new, efficient heterojunction composite for the rapid and enhanced photocatalytic degradation of Rhodamine B dye and Moxifloxacin antibiotic under UV irradiation and Sunlight

Manzoor Ishtiaq,R. Vijayaraghavan
DOI: https://doi.org/10.1039/d4nj03148b
IF: 3.3
2024-10-04
New Journal of Chemistry
Abstract:In this study, ZnO2 nanoparticles and neoteric ZnO2-SnO2 composite have been successfully prepared for the investigation of photocatalytic degradation of dye and pharmaceutical contaminants. Various characterization techniques were employed to analyse the as-prepared photocatalysts. The degradation involves the irradiation of light on materials, resulting in generation of charge carriers pairs (e─- h+), which react with O2, H2O to produce reactive oxygen species (ROS) viz •O2─, •OH, that decontaminate pollutants. The photocatalytic activity of as-prepared catalysts was tested for degradation of Rhodamine B (Rh B) dye and pharmaceutical antibiotic Moxifloxacin (MOX). The results indicate that new composite-catalyst outperforms ZnO2 in degradation of Rh B and MOX, which can be attributed to better separation and transfer of photoexcited charge carriers and thereby achieving degradation percentages of 96.4% in 30 minutes for Rh B and 95.1% in 20 minutes for MOX after irradiation of UV light. However, under natural sunlight degradation percentages of Rh B and MOX are 96.2% in 105 minutes and 77.5% in 90 minutes respectively. The degradation rates of composite-catalyst are found to be 2.3 and 4.75 times higher than that of ZnO2 for Rh B and MOX respectively. Furthermore, scavenging activity was performed which reveals that •OH radicals predominantly contribute to degradation of contaminants. The Rh B degradation pathway was studied by HR-MS technique and toxicity assessment was done using ECOSAR software. More importantly, present study highlights the performance of the catalyst ZnO2-SnO2 which is reported for the first time.
chemistry, multidisciplinary
What problem does this paper attempt to address?